Director, Corporate Strategy

Takeda•Boston, MA

1d•$177,000 - $278,080•Hybrid

About The Position

The Director, Corporate Strategy leads strategic analyses and cross-functional projects that inform Takeda’s long-term direction, enterprise priorities, portfolio choices, and major corporate decisions. Reporting to the Head of Corporate Strategy, the Director works with Strategy & Portfolio Development, R&D, Commercial, Finance, Business Development, External Portfolio Innovation, and other functions to evaluate strategic alternatives, assess external trends, and develop recommendations for senior leadership. The role leads defined corporate strategy projects and workstreams, supports enterprise scenario planning, conducts industry and competitive benchmarking, and contributes to strategic assessments of corporate development opportunities. It synthesizes complex scientific, commercial, financial, and external information into clear insights and executive-ready materials. The position is based in Cambridge, Massachusetts, in a hybrid work arrangement, with approximately 15% global travel.

Requirements

At least 8 years of experience in corporate strategy, portfolio strategy, management consulting, business development, investment banking, market analytics, or a related role; significant pharmaceutical or biotech experience is preferred.
Experience leading analytical workstreams and developing recommendations on complex corporate, portfolio, growth, or transaction-related questions.
Experience working effectively in a global, cross-functional, matrixed organization.
BA/BS degree required.
Strong strategic and analytical problem-solving skills, including structuring ambiguous questions, developing hypotheses, identifying relevant analyses, and drawing actionable conclusions.
Ability to integrate scientific, clinical, commercial, financial, competitive, and policy-related information into coherent strategic insights.
Understanding of the global biopharma industry, including drug development, commercialization, portfolio management, business development, market access, and competitive dynamics.
Experience conducting scenario analysis, market assessment, competitive intelligence, industry benchmarking, or strategic due diligence.
Strong quantitative and financial capabilities, including experience with business cases, valuation concepts, scenario modeling, market forecasting, sensitivity analysis, or portfolio analysis.
Ability to evaluate emerging technologies and external trends, including AI, digital health, geopolitical developments, healthcare policy, and evolving business models.
Excellent written and verbal communication skills and ability to prepare clear, concise, compelling materials for senior executives.
Ability to synthesize complex information and identify leadership-relevant insights, implications, and decisions.
Strong interpersonal and stakeholder-management skills, including ability to build relationships and influence across functions, cultures, and geographies.
Strong project-management skills, including ability to lead multiple workstreams, manage competing priorities, and deliver high-quality work under tight timelines.
Intellectual curiosity, sound judgment, attention to detail, and willingness to appropriately challenge assumptions and established perspectives.
Ability to use AI and technology responsibly to increase analytical productivity, identify insights, and accelerate high-quality strategic recommendations.
Based in Cambridge, Massachusetts, in a hybrid arrangement, with approximately 15% global travel.

Nice To Haves

MBA, PhD, MD, or equivalent advanced degree preferred.
Significant experience in the pharmaceutical or biotech industry preferred.
Familiarity with mergers and acquisitions, divestitures, spin-outs, partnerships, licensing, or other corporate development activities.

Responsibilities

Lead corporate strategy projects and analytical workstreams related to long-term strategy, growth priorities, portfolio, geographic presence, capabilities, and competitive positioning.
Support enterprise scenario planning and evaluate the implications of alternative scenarios for strategy, portfolio, investments, and capabilities.
Analyze strategic alternatives and articulate assumptions, opportunities, risks, trade-offs, and potential financial and organizational implications.
Develop strategic evaluations, recommendations, and materials for major corporate decisions and discussions with senior leadership and the Board of Directors.
Conduct industry and peer benchmarking across competitor portfolios, R&D and commercial investments, business development, geographic exposure, financial performance, capabilities, and business models.
Monitor biopharma and healthcare business models and assess the impact of AI, digital health, scientific innovation, geopolitical developments, healthcare policy, market access changes, and other external trends.
Conduct strategic assessments of mergers and acquisitions, divestitures, spin-outs, and other corporate development scenarios.
Develop market, competitor, portfolio, financial, and strategic analyses to support enterprise strategy, annual planning, and capital allocation discussions.
Synthesize scientific, clinical, commercial, financial, competitive, policy-related, and external information into decision-ready insights and recommendations.
Prepare presentations, written summaries, strategic narratives, and other executive materials for senior leadership and Board discussions.
Work with business units, therapeutic areas, and functions to understand priorities and incorporate relevant insights into enterprise strategy and planning.
Monitor global biopharma trends, competitor actions, policy and regulatory developments, technology disruption, financial-market conditions, and emerging risks and opportunities.
Manage strategy projects from problem definition and analytical design through stakeholder engagement, recommendation development, and final communication.
Use AI, advanced analytics, and emerging technology tools to improve research, analysis, scenario development, benchmarking, and preparation of strategic materials.